|
Market Closed -
Toronto S.E.
22:55:00 20/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 9.710 CAD | +5.77% |
|
-1.92% | +22.60% |
| 10-05 | Satellos Bioscience Granted Composition of Matter Patent for Forazapadin by USPTO | MT |
| 10-05 | Satellos Bioscience Receives US Patent for Forazapadin | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +5.77% | -1.92% | -25.48% | -17.15% | +22.60% | +2.43% | +102.29% | -46.06% | - | 147M | |
| +0.79% | -6.16% | -7.71% | +18.87% | +62.91% | +49.32% | +74.50% | +5.10% | - | 66.34B | |
| -1.31% | +5.64% | +12.68% | +9.65% | +14.99% | +10.74% | +88.77% | -17.66% | +234.45% | 52.92B | |
| -0.13% | +4.37% | -10.28% | +2.45% | +8.65% | +6.98% | +72.72% | +206.37% | +5,205.18% | 54.82B | |
| +0.74% | +2.75% | +0.54% | +31.36% | +18.83% | +26.31% | +45.29% | +6.49% | +259.92% | 44.09B | |
| +3.87% | +10.15% | +9.59% | +23.80% | +26.56% | +20.69% | +132.73% | +3.19% | +1,065.86% | 43.72B | |
| +7.91% | +4.30% | +2.93% | +8.96% | +146.77% | +263.91% | +602.72% | +629.86% | - | 42.13B | |
| -0.40% | +9.85% | +10.03% | +14.37% | +14.51% | +17.04% | +59.17% | +9.63% | +167.54% | 33.96B | |
| -1.30% | -0.68% | -6.79% | +27.25% | +57.12% | +37.15% | +7.04% | -56.32% | - | 26.17B | |
| +0.35% | +5.32% | +15.62% | +41.05% | +28.91% | +36.24% | +26.05% | -11.30% | +130.22% | 23.37B | |
| +2.20% | +2.43% | -5.09% | -1.07% | -4.23% | -15.54% | +0.29% | -66.16% | - | 22.9B | |
| +0.40% | -1.16% | -20.27% | -10.61% | -45.03% | -43.02% | +281.46% | +258.18% | +579.96% | 20.89B | |
| +0.45% | +2.06% | +1.65% | +17.90% | +10.82% | +14.33% | +171.51% | +230.99% | +1,913.68% | 17.37B | |
| +2.73% | +8.20% | +10.33% | +15.96% | +46.91% | +86.42% | +205.02% | +197.55% | +448.47% | 15.95B | |
| +2.25% | +3.70% | +3.43% | +15.91% | +29.39% | +29.18% | +71.24% | -22.37% | +89.66% | 15.41B | |
| +1.90% | +4.98% | -1.01% | -6.92% | - | - | - | - | - | 15.39B | |
| -1.70% | -0.86% | -2.12% | -1.70% | +172.60% | +149.75% | +358.65% | +1,398.21% | +710.15% | 14.65B | |
| +5.14% | +5.49% | +13.45% | +43.58% | +58.14% | +71.31% | +70.14% | -25.15% | +280.06% | 15.06B | |
| +1.11% | +8.23% | -4.52% | -7.49% | +20.65% | +0.47% | +556.77% | - | - | 14.25B | |
| +3.60% | +5.99% | +6.14% | +4.82% | -4.41% | -7.57% | -23.17% | -36.96% | +105.58% | 13.44B | |
| Average | +1.72% | +3.63% | +0.16% | +11.55% | +36.14% | +39.80% | +152.80% | +147.98% | +860.82% | 27.65B | |
| Weighted average by Cap. | +1.38% | +4.23% | +1.03% | +14.29% | +37.71% | +44.27% | +142.87% | +127.21% | +1,188.22% |
- Stock Market
- Stocks
- MSCL Stock
- Sector Satellos Bioscience Inc.
Select your edition
All financial news and data tailored to specific country editions
